This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02557/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02557/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02557/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02557/identifier/kegg-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02557/identifier/pdb/

Statements

Subject Item
n2:DB02557
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02557 n11:DB02557
dcterms:title
Phosphoramidon
adms:identifier
n8:46506179 n9:RDF n10:46936424 n12:DB02557 n13:C00563
n3:synthesisReference
Guillaume de Nanteuil, Georges Remond, Tony Verbeuren, "Preparation of phosphoramidon." U.S. Patent US5608045, issued December, 1989.
n3:IUPAC-Name
n4:271B4278-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B427E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B427D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B427A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B427B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B427C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4276-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4274-363D-11E5-9242-09173F13E4C5 n4:271B4277-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4275-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4284-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4285-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B427F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4280-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4282-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4281-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4283-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
36357-77-4
n3:Bioavailability
n4:271B428A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B428C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B428D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4289-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4288-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B428B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4279-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4286-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4287-363D-11E5-9242-09173F13E4C5